Despite these important developments in understanding the role of inflammatory signaling in prevalent neuropsychiatric disorders such as migraine and depression, how HMGB1 is released from neurons and how inflammatory signaling is initiated in the absence of apparent cell injury are not well characterized. This evidence concerns the gene HMGB1 and migraine disorder.